Skip to main content
SpringerLink
Log in

Pancreas

  • Chapter
Cancer Precursors

  • 238 Accesses

Conclusions

Pancreatic cancer is one of the deadliest of all of the cancers. New approaches to detect early pancreatic cancer and pancreatic cancer precursors, and to prevent pancreatic cancer in populations at risk, are urgently needed. We believe that the revolution in our understanding of the molecular genetics of pancreatic neoplasia which has occurred in the last 10 years will provide a basis for the development of these new approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee RT, Murray T, Bolden S, et al. Cancer Statistics, 2000. CA Cancer J Clin 2000; 50:7–33.

    PubMed  CAS  Google Scholar 

  2. Niederhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer. Cancer 1995; 76:1671–7.

    PubMed  CAS  Google Scholar 

  3. Warshaw AL, Castillo CFD. Pancreatic carcinoma. N Engl J Med 1992; 326:455–65.

    PubMed  CAS  Google Scholar 

  4. Gold EB, Goldin SB. Epidemiology of and risk factor for pancreatic cancer. Surg Oncol Clin N Am 1998; 7:67–91.

    PubMed  CAS  Google Scholar 

  5. Solcia E, Capella C, Klöppel G. Atlas of tumor pathology: tumors of the pancreas, 3rd Series ed. Washington, DC: Armed Forces Institute of Pathology, 1997.

    Google Scholar 

  6. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43:1418–28.

    PubMed  CAS  Google Scholar 

  7. Lüttges J, Reinecke-Lüthge A, Mollmann B, et al. Duct changes of K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch 1999; 435:461–8.

    PubMed  Google Scholar 

  8. Riela A, Zinsmeister AR, Melton LJI, et al. Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988. Mayo Clin Proc 1992; 67: 839–45.

    PubMed  CAS  Google Scholar 

  9. Levin DL, Connelly RR, Devesa SS. Demographic characteristics of cancer of the pancreas: mortality, incidence, and survival. Cancer 1981; 47(Suppl):1456–68.

    PubMed  CAS  Google Scholar 

  10. Kovi J, Heshmat MY. Incidence of cancer in negroes in Washington, D.C. and selected African cities. Am J Epidemiol 1972; 96:401–13.

    PubMed  CAS  Google Scholar 

  11. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594–606.

    PubMed  CAS  Google Scholar 

  12. Falk RT, Pickle LW, Fontham ET, et al. Life-style risk factors for pancreatic cancer in Louisana: a case-control study. Am J Epidemiol 1988; 128:324–36.

    PubMed  CAS  Google Scholar 

  13. Fraumeni JF Jr. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 1975; 35:3437–46.

    PubMed  Google Scholar 

  14. Ghadirian P, Simard A, Baillargeon J. Tobacco, alcohol, and coffee and cancer of the pancreas. A population-based, case-control study in Quebec, Canada. Cancer 1991; 67:2664–70.

    PubMed  CAS  Google Scholar 

  15. Howe GR, Jain M, Burch JD, et al. Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int J Cancer 1991; 47:323–8.

    PubMed  CAS  Google Scholar 

  16. Mack TM, Yu MC, Hanisch R, et al. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76:49–60.

    PubMed  CAS  Google Scholar 

  17. Mills PK, Beeson WL, Abbey DE, et al. Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists. Cancer 1988; 61:2578–85.

    PubMed  CAS  Google Scholar 

  18. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999; 91: 535–41.

    Article  PubMed  CAS  Google Scholar 

  19. Wynder EL, Mabuchi K, Maruchi N, et al. A case control study of cancer of the pancreas. Cancer 1973; 31:641–8.

    PubMed  CAS  Google Scholar 

  20. Mulder I, van Genugten ML, Hoogenveen RT, et al. The impact of smoking on future pancreatic cancer: a computer simulation. Ann Oncol 1999; 10(4 Suppl):74–8.

    PubMed  Google Scholar 

  21. Fujii H, Egami H, Chaney W, et al. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 1990; 3:296–301.

    PubMed  CAS  Google Scholar 

  22. Schuller HM, Jorquera R, Reichert A, et al. Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitorsamino)-1-(3 pyridyl)-1-butanonel. Cancer Res 1993; 53:2498–501.

    PubMed  CAS  Google Scholar 

  23. Rivenson A, Hoffmann D, Prokopczyk B, et al. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988; 48:6912–7.

    PubMed  CAS  Google Scholar 

  24. Hruban RH, van Mansfeld ADM, Offerhaus GJA, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143:545–54.

    PubMed  CAS  Google Scholar 

  25. Berger DH, Chang H, Wood M, et al. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status. Cancer 1999; 85:326–32.

    Article  PubMed  CAS  Google Scholar 

  26. Topal MD. DNA repair, oncogenes and carcinogenesis. Carcinogenesis 1988; 9:691–6.

    PubMed  CAS  Google Scholar 

  27. Gambill EE. Pancreatitis associated with pancreatic carcinoma: A study of 26 cases. Mayo Clin Proc 1971; 46:174–7.

    PubMed  CAS  Google Scholar 

  28. Finch MD, Howes N, Ellis I, et al. Hereditary pancreatitis and familial pancreatic cancer. Digestion 1997; 58:564–9.

    PubMed  CAS  Google Scholar 

  29. Chari ST, Mohan V, Pitchumoni CS, et al. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 1994; 9:62–6.

    Article  PubMed  CAS  Google Scholar 

  30. Gold EB, Cameron JL. Chronic pancreatitis and pancreatic cancer. N Engl J Med 1993; 328:1485–6.

    Article  PubMed  CAS  Google Scholar 

  31. Lerch MM, Ellis I, Whitcomb DC, et al. Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst 1999; 91:723–4.

    Article  PubMed  CAS  Google Scholar 

  32. Lowenfels AB, Maisonneuve EP, Dimagno YE, et al. International Hereditary Pancreatitis Study Group. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997; 89:442–6.

    Article  PubMed  CAS  Google Scholar 

  33. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993; 328:1433–7.

    Article  PubMed  CAS  Google Scholar 

  34. Whitcomb DC. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut 1999; 45:317–22.

    PubMed  CAS  Google Scholar 

  35. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14:141–5.

    Article  PubMed  CAS  Google Scholar 

  36. Volkholz H, Stolte M, Becker V. Epithelial dysplasias in chronic pancreatitis. Virchows Arch [A] Pathol Anat Histol 1982; 396:331–49.

    CAS  Google Scholar 

  37. Gansauge S, Schmid RM, Muller J, et al. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg 1998; 85:337–40.

    Article  PubMed  CAS  Google Scholar 

  38. Tabata T, Fujimori T, Maeda S, et al. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993; 14:237–44.

    PubMed  CAS  Google Scholar 

  39. Orth M, Gansauge F, Gansauge S, et al. Kras mutations at codon 12 are rare events in chronic pancreatitis. Digestion 1998; 59:120–4.

    Article  PubMed  CAS  Google Scholar 

  40. Tabata T, Fujimori T, Maeda S, et al. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1993; 14:237–44.

    PubMed  CAS  Google Scholar 

  41. van Rees BP, Tascilar M, Hruban RH, et al. Remote partial gastrectomy as a risk factor for pancreatic cancer: potential for preventive strategies. Ann Oncol 1999; 10(Suppl 4):204–7.

    PubMed  Google Scholar 

  42. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999; 80:1830–7.

    Article  PubMed  CAS  Google Scholar 

  43. Chow W-H, Gridley G, Nyren O, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 1995; 87:1–2.

    Google Scholar 

  44. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273:1605–9.

    Article  PubMed  CAS  Google Scholar 

  45. Gapstur SM, Gann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283:2552–8.

    Article  PubMed  CAS  Google Scholar 

  46. Hruban RH, Petersen GM, Ha PK, et al. Genetics of pancreatic cancer: from genes to families. Surg Oncol Clin North Am 1998; 7:1–23.

    CAS  Google Scholar 

  47. Hruban RH, Petersen GM, Goggins M, et al. Familial pancreatic cancer. Ann Oncol 1999; 10(Suppl):69–73.

    PubMed  Google Scholar 

  48. Lynch HT, Fitzsimmons ML, Smyrk TC, et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990; 85:54–60.

    PubMed  CAS  Google Scholar 

  49. Lynch HT, Smyrk T, Kern SE, et al. Familial pancreatic cancer: a review. Semin Oncol 1996; 23:251–75.

    PubMed  CAS  Google Scholar 

  50. Dat NM, Sontag SJ. Pancreatic carcinoma in brothers. Ann Intern Med 1982; 97:282.

    PubMed  CAS  Google Scholar 

  51. Ehrenthal D, Haeger L, Griffin T, et al. Familial pancreatic adenocarcinoma in three generations. Cancer 1987; 59:1661–4.

    PubMed  CAS  Google Scholar 

  52. Grajower MM. Familial pancreatic cancer. Ann Intern Med 1983; 98:111.

    PubMed  CAS  Google Scholar 

  53. Katkhouda N, Mouiel J. Pancreatic cancer in mother and daughter. Lancet 1986; 2:747.

    PubMed  CAS  Google Scholar 

  54. Ghadirian P, Simard A, Baillargeon J. Cancer of the pancreas in two brothers and one sister. Int J Pancreatol 1987; 2:383–91.

    PubMed  CAS  Google Scholar 

  55. MacDermott RP, Kramer P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology 1973; 65:137–9.

    PubMed  CAS  Google Scholar 

  56. Reimer RR, Fraumeni JF Jr, Ozols RF, et al. Pancreatic cancer in father and son. Lancet 1977; 1:911–12.

    PubMed  CAS  Google Scholar 

  57. Brinkley D. The Unfinished Presidency: Jimmy Carter’s journey beyond the White House. New York: Penguin Group, 1998.

    Google Scholar 

  58. Fernandez E, La Vecchia C, D’Avanzo B, et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3:209–12.

    PubMed  CAS  Google Scholar 

  59. Ghadirian P, Boyle P, Simard A, et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991; 10:183–96.

    PubMed  CAS  Google Scholar 

  60. Price TF, Payne RL, Oberleitner MG. Familial pancreatic cancer in south Louisiana. Cancer Nurs 1996; 19:275–82.

    PubMed  CAS  Google Scholar 

  61. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001; 7:738–44.

    PubMed  CAS  Google Scholar 

  62. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996; 56:5360–4.

    PubMed  CAS  Google Scholar 

  63. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000; 60: 409–16.

    PubMed  CAS  Google Scholar 

  64. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 1997; 386:804–10.

    Article  PubMed  CAS  Google Scholar 

  65. Ozcelik H, Schmocker B, DiNicola N, et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 1997; 16:17–8.

    PubMed  CAS  Google Scholar 

  66. Tulinius H, Olafsdottir GH, Sigvaldason H, et al. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994; 31:618–21.

    PubMed  CAS  Google Scholar 

  67. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinomas of the pancreas: a newly described and characterized entity. Am J Pathol 2000; 156:1641–51.

    PubMed  CAS  Google Scholar 

  68. Lynch HT, Voorhees GJ, Lanspa S, et al. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 1985; 52:271–3.

    PubMed  CAS  Google Scholar 

  69. Su GH, Hruban RH, Bova GS, et al. Germline and somatic mutations of the STKII/LKBI Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999; 154:1835–40.

    PubMed  CAS  Google Scholar 

  70. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316: 1511–4.

    PubMed  CAS  Google Scholar 

  71. Bergman W, Watson P, de Jong J, et al. Systemic cancer and the FAMMM syndrome. Br J Cancer 1990; 61:932–6.

    PubMed  CAS  Google Scholar 

  72. Ciotti P, Strigini P, Bianchi-Scarra G. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group [letter; comment]. N Engl J Med 1996; 334:469–70.

    Article  PubMed  CAS  Google Scholar 

  73. Moskaluk CA, Hruban H, Lietman A, et al. Novel germline p16 (INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. [Mutations in Brief No. 148 online.] Hum Mutat 1998; 12:70.

    Article  PubMed  CAS  Google Scholar 

  74. Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16 INK4 mutations. N Engl J Med 1995; 333:970–4.

    Article  PubMed  CAS  Google Scholar 

  75. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 1991; 6:127–31.

    Article  PubMed  CAS  Google Scholar 

  76. Jeghers HMD, McKusick VAMD, Katz KHMD. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N Engl J Med 1949; 241:992–1005.

    Google Scholar 

  77. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18:38–43.

    Article  PubMed  CAS  Google Scholar 

  78. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535–49.

    PubMed  CAS  Google Scholar 

  79. Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch Syndromes I and II). Ann Surg 1987; 206: 289–95.

    PubMed  Google Scholar 

  80. Lynch HT, Lanspa S, Smyrk T, et al. Hereditary nonpolyposis colorectal cancer (Lynch Syndromes I & II). Genetics, pathology, natural history, and cancer control, part 1. Cancer Genet Cytogenet 1991; 53:143–60.

    PubMed  CAS  Google Scholar 

  81. Lynch HT, Krush AJ,. Heredity and adenocarcinoma of the colon. Gastroenterology 1967; 53: 517–27.

    PubMed  CAS  Google Scholar 

  82. Lynch HT, Smyrk T, Lynch JF. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int J Cancer 1996; 69:38–43.

    Article  PubMed  CAS  Google Scholar 

  83. Goggins M, Offerhaus GJA, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998; 152:1501–7.

    PubMed  CAS  Google Scholar 

  84. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71:677–85.

    PubMed  CAS  Google Scholar 

  85. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nat Med 1996; 2:169–74.

    PubMed  CAS  Google Scholar 

  86. Parsons R, Li G-M, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75:1227–36.

    Article  PubMed  CAS  Google Scholar 

  87. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215–36.

    Article  PubMed  CAS  Google Scholar 

  88. Kunkel TA. Slippery DNA and diseases. Nature 1993; 365:207–8.

    Article  PubMed  CAS  Google Scholar 

  89. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75:1027–38.

    Article  PubMed  CAS  Google Scholar 

  90. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol 2000; 156:1821–5.

    PubMed  CAS  Google Scholar 

  91. Hruban RH, Wilentz RE, Goggins M, et al. Pathology of incipient pancreatic cancer. Ann Oncol 1999; 10(Suppl):9–11.

    PubMed  Google Scholar 

  92. Hruban RH, Goggins M, Parsons J, et al. Progression model for pancreatic cancer. Clin Cancer Res 2000; 6:2969–72.

    PubMed  CAS  Google Scholar 

  93. Sommers SC, Murphy SA, Warren S. Pancreatic duct hyperplasia and cancer. Gastroenterology 1954; 27:629–40.

    PubMed  CAS  Google Scholar 

  94. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976; 36:2690–8.

    PubMed  CAS  Google Scholar 

  95. Brat DJ, Lillemoe KD, Yeo CJ, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998; 22:163–9.

    Article  PubMed  CAS  Google Scholar 

  96. Brockie E, Anand A, Albores-Saavedra J. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma. Ann Diagn Pathol 1998; 2: 286–92.

    PubMed  CAS  Google Scholar 

  97. Day JD, DiGiuseppe JA, Yeo CJ, et al. Immunohistochemical evaluation of HER-2/neu oncogene expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996; 27:119–24.

    PubMed  CAS  Google Scholar 

  98. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57:2140–3.

    PubMed  CAS  Google Scholar 

  99. DiGiuseppe JA, Hruban RH, Offerhaus GJA, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144:889–95.

    PubMed  CAS  Google Scholar 

  100. Yamano M, Fujii H, Takagaki T, et al. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000; 156:2123–33.

    PubMed  CAS  Google Scholar 

  101. Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 2000; 60:2002–6.

    PubMed  CAS  Google Scholar 

  102. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58: 4740–4.

    PubMed  CAS  Google Scholar 

  103. Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000; 156:1767–71.

    PubMed  CAS  Google Scholar 

  104. DiGiuseppe JA, Hruban RH, Goodman SN, et al. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994; 101:684–8.

    PubMed  CAS  Google Scholar 

  105. Iacobuzio-Donahue CA, Klimstra D, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal carcinomas. Am J Pathol 2000; 157:755–61.

    PubMed  CAS  Google Scholar 

  106. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996; 39:457–64.

    PubMed  CAS  Google Scholar 

  107. Loftus EV, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome and nomenclature. Gastroenterol 1996; 110:1909–18.

    Google Scholar 

  108. Morohoshi T, Kanda M, Asanuma K, et al. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989; 64:1329–35.

    PubMed  CAS  Google Scholar 

  109. Nagai E, Ueki T, Chijiiwa K, et al. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia.“ Histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 1995; 19:576–89.

    PubMed  CAS  Google Scholar 

  110. Paal E, Thompson LD, Przygodzki RM, et al. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999; 12:518–28.

    PubMed  CAS  Google Scholar 

  111. Shyr Y-M, Su CH, Tsay SH, et al. Mucin producing neoplasms of the pancreas: intraductal papillary and mucinous cystic neoplasms. Ann Surg 1996; 223:141–6.

    Article  PubMed  CAS  Google Scholar 

  112. Tian F, Myles J, Howard JM. Mucinous pancreatic ductal ectasia of latent malignancy: an emerging clinicopathologic entity. Surgery 1992; 111:109–13.

    PubMed  CAS  Google Scholar 

  113. Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997; 151:1447–54.

    PubMed  CAS  Google Scholar 

  114. Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases. Cancer 1991; 67:634–7.

    PubMed  CAS  Google Scholar 

  115. Z’graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997; 226:491–8.

    PubMed  CAS  Google Scholar 

  116. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000; 127: 536–44.

    Article  PubMed  CAS  Google Scholar 

  117. Wilentz RE, Albores-Saavedra J, Zahurak M, et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999; 23:1320–7.

    Article  PubMed  CAS  Google Scholar 

  118. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucious cystic tumors. Am J Surg Pathol 1999; 23:410–22.

    Article  PubMed  CAS  Google Scholar 

  119. Wilentz RE, Slebos RJC, Hruban RH. Screening for pancreatic cancer using techniques to detect altered gene products. In: Reber HA (ed) Pancreatic cancer: pathogenesis, diagnosis, and treatment. Totowa: Humana Press, Inc, 1997, pp. 113–36.

    Google Scholar 

  120. Hruban RH, Yeo CJ, Kern SE. Screening for pancreatic cancer. In: Kramer B, Provok P, Gohagan J (ed) Screening theory and practice. New York: Dekker Publishing, 1999, pp. 441–59.

    Google Scholar 

  121. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221:721–33.

    PubMed  CAS  Google Scholar 

  122. Ritts RE, Pitt HA. CA 19-9 in pancreatic cancer. Surg Oncol Clin North Am 1998; 7:93–101.

    CAS  Google Scholar 

  123. Goggins M, Canto M, Hruban RH. Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 2000; 74: 243–8.

    Article  PubMed  CAS  Google Scholar 

  124. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999; 131: 247–55.

    PubMed  CAS  Google Scholar 

  125. Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997; 57:326–31.

    PubMed  CAS  Google Scholar 

  126. Iwao T, Hiyama E, Yokoyama T, et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 1997; 89:1621–3.

    Article  PubMed  CAS  Google Scholar 

  127. Morales CP, Burdick JS, Saboorian MH, et al. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 1998; 48:402–5.

    PubMed  CAS  Google Scholar 

  128. Suehara N, Mizumoto K, Kusumoto M, et al. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer. Am J Gastroenterol 1997; 93:1967–71.

    Google Scholar 

  129. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997; 3 (12 Pt 1):2479–83.

    PubMed  CAS  Google Scholar 

  130. Tsutsumi M, Tsujiuchi T, Ishikawa O, et al. Increased telomerase activities in human pancreatic duct adenocarcinomas. Jpn J Cancer Res 1997; 88:971–6.

    PubMed  CAS  Google Scholar 

  131. Uehara H, Nakaizumi A, Tatsuta M, et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol 1999; 94:2513–18.

    Article  PubMed  CAS  Google Scholar 

  132. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54:3568–73.

    PubMed  CAS  Google Scholar 

  133. Wilentz RE, Chung CH, Sturm PDJ, et al. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer 1998; 82:96–103.

    Article  PubMed  CAS  Google Scholar 

  134. Berthélemy P, Bouisson M, Escourrou J, et al. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 1995; 123:188–91.

    PubMed  Google Scholar 

  135. Ueki T, Toyota M, Sohn TA, et al. Hypermethylation of multiple genes in pancreatic carcinoma. Cancer Res 2000; 60:1835–9.

    PubMed  CAS  Google Scholar 

  136. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72:141–96.

    PubMed  CAS  Google Scholar 

  137. Merlo A, Herman JG, Mao L, et al. 5’ CpG island methylation is associated with transcriptional silencing of the tumor-suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1:686–92.

    Article  PubMed  CAS  Google Scholar 

  138. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95:11891–6.

    Article  PubMed  CAS  Google Scholar 

  139. Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression. Science 1995; 270:484–7.

    PubMed  CAS  Google Scholar 

  140. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science 1997; 276:1268–72.

    PubMed  CAS  Google Scholar 

  141. Zhou W, Sokoll LJ, Bruzek DJ, et al. Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev 1998; 7:109–12.

    PubMed  CAS  Google Scholar 

  142. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray [comments]. Science 1995; 270:467–70.

    PubMed  CAS  Google Scholar 

  143. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999; 5:1966–75.

    PubMed  CAS  Google Scholar 

  144. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000; 60:1677–82.

    PubMed  CAS  Google Scholar 

  145. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines [comments]. Nat Genet 2000; 24:227–35.

    PubMed  CAS  Google Scholar 

  146. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000; 21:1164–77.

    Article  PubMed  CAS  Google Scholar 

  147. Molina MA, Sitja-Arnau M, Lemoine MG, et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 1999; 59:4356–62.

    PubMed  CAS  Google Scholar 

  148. Yip-Schneider MT, Barnard DS, Billings SD, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 2000; 21:139–46.

    Article  PubMed  CAS  Google Scholar 

  149. Koshiba T, Hosotani R, Miyamoto Y, et al. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int J Pancreatol 1999; 26:69–76.

    PubMed  CAS  Google Scholar 

  150. Okami J, Yamamoto H, Fujiwara Y, et al. Over-expression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 1999; 5:2018–24.

    PubMed  CAS  Google Scholar 

  151. Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59:987–90.

    PubMed  CAS  Google Scholar 

  152. Evans JP, Burke W, Chen R, et al. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 1995; 32:330–5.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ralph H. Hruban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Iacobuzio-Donahue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Goggins
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Oncology and Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  2. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA

    Thomas E. Rohan MB, BS, PhD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Hruban, R.H., Iacobuzio-Donahue, C., Goggins, M. (2002). Pancreas. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_13

Download citation

  • DOI: https://doi.org/10.1007/0-387-21605-7_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95188-1

  • Online ISBN: 978-0-387-21605-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation